Alpha 1-antitrypsin deficiency: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
mNo edit summary |
||
Line 33: | Line 33: | ||
==[[Alpha 1-antitrypsin deficiency screening|Screening]]== | ==[[Alpha 1-antitrypsin deficiency screening|Screening]]== | ||
==[[Alpha 1-antitrypsin deficiency natural history|Natural History, Complications and Prognosis]]== | ==[[Alpha 1-antitrypsin deficiency natural history, complications, and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== |
Revision as of 13:39, 20 July 2016
Alpha 1-antitrypsin deficiency Microchapters |
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Alpha 1-antitrypsin deficiency On the Web |
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency |
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
For patient information, click here Template:DiseaseDisorder infobox
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alpha 1-antitrypsin deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies